Mark S Anderson

30PUBLICATIONS

447CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|May 25, 2026

Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency.

|Jan 09, 2026

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial.

Renee R Fedak, Rachel N Ruggerie, Yufei Shan

|Mar 12, 2025

Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.

Lauren E Higdon, Laura A Cooney, Elisavet Serti

|Jan 17, 2025

Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.

Hailyn V Nielsen, Letitia Yang, James L Mueller

|Oct 01, 2024

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Jérémie Rosain, Tom Le Voyer, Xian Liu

|Aug 21, 2024

A balancing act in the control of self-antigen expression.

Michael R Waterfield, Mark S Anderson

Pageof 5

Frequent Collaborators

James M Gardner

Joseph L DeRisi

Corey N Miller

Jean-Laurent Casanova

Michael R Wilson

Aaron Bodansky

Audrey V Parent

Ansuman T Satpathy

Sara E Vazquez

Alexander R Gupta

Frequent Collaborators

James M Gardner

Joseph L DeRisi

Corey N Miller

Jean-Laurent Casanova